UBS upgraded Synovus to Buy from Neutral with a $42 price target. The firm says the fixed asset repricing story is driving solid 2025 NII despite 8 cuts in 2024/2024 in the firm’s forecast, which positions UBS the firm above consensus estimates for 2025 EPS, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SNV:
